A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy - Wood, Robert A.; Kim, Jennifer S.; Lindblad, Robert; Nadeau, Kari; Henning, Alice K.; Dawson, Peter; Plaut, Marshall; Sampson, Hugh A. (Journal of allergy and clinical immunology, 2016)
Keywords: Administration, Oral; Adolescent; Adult; Allergy and Immunology; Anti-Allergic Agents - therapeutic use; Asthma; Child; Combined Modality Therapy; desensitization; Desensitization, Immunologic - methods; dose-related adverse reactions; double-blind; Double-Blind Method; Drug Administration Schedule; FDA approval; Female; Food; Food allergies; Humans; Immunotherapy; Logistic Models; Male; Milk; Milk allergy; Milk Hypersensitivity - therapy; omalizumab; Omalizumab - therapeutic use; oral immunotherapy; placebo-controlled trial; Proteins; sustained unresponsiveness; Treatment Outcome; Young Adult; SU; dose-related adverse reactions; MOIT; oral immunotherapy; OFC; desensitization; placebo-controlled trial; APC; SCD; CMA; SPT; sustained unresponsiveness; Milk allergy; omalizumab; OIT; double-blind; Oral food challenge; Skin prick test; Successfully consumed dose; Cow's milk allergy; Milk oral immunotherapy; Antigen-presenting cell